Vaxcyte (PCVX) Other Working Capital Changes (2024 - 2026)
Vaxcyte (PCVX) posted quarterly Other Working Capital Changes of -$1.3 million for Q1 2026, down 108.03% year-over-year from $16.0 million in Q1 2025, and down 103.88% quarter-over-quarter from $33.1 million in Q4 2025.
Vaxcyte (PCVX) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Vaxcyte (PCVX) has reported Other Working Capital Changes for 3 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 108.03% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at $29.1 million (down 51.27% YoY), while the FY2025 annual figure was $46.4 million, up 10.71% from the prior year.
- Other Working Capital Changes retreated to -$1.3 million in Q1 2026 per PCVX's latest filing, from $33.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $24.0 million in Q4 2024 and bottomed at -$16.5 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $2.5 million across 5 years, with a median of $1.6 million in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 986.86% in 2025 and fell as far as 158.92% in 2025.
- Vaxcyte's Other Working Capital Changes stood at $43.2 million in 2024, then declined by 23.21% to $33.1 million in 2025, then tumbled by 103.88% to -$1.3 million in 2026.
- Business Quant data shows PCVX's Other Working Capital Changes at -$1.3 million in Q1 2026, $33.1 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -851,000.00 |
| Jun 30, 2026 | -851,000.00 |
| Jun 30, 2026 | -851,000.00 |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | 33.14 Mn |
| Dec 31, 2025 | 33.14 Mn |
| Dec 31, 2025 | 33.14 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -1.36 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 43.15 Mn |
| Dec 31, 2024 | 43.15 Mn |